IAM Stock Analysis Today
Updated Nov 10, 2026 · trends, key levels, insider activity and news
Is IAM bullish or bearish today?
Daily trend: Uptrend (starting) — turns down below $5.95
SEPT signal: Accumulation · Strong Bearish
IAM trend by timeframe
| Daily | Uptrend (starting) |
|---|---|
| 4 hour | Leaning Bullish |
| 1 hour | Expanding |
| 15 min | Leaning Bearish |
| 5 min | Expanding |
Trends are calculated from price structure and update during market hours.
IAM support and resistance levels
Resistance (above)
$13.963 touches
$25.001 touches
Support (below)
$11.0015 touches
$7.002 touches
Upside zones: $17.95 / $18.68 / $19.40
See all levels on the live chart →Insider and institutional activity
Insiders
Neutral30-day buys / sells
0 / 030-day net
—Hedge fund holders
0Latest IAM news and filings
- AnalystBenzinga
Supernus Pharmaceuticals receives bullish analyst coverage initiation
An analyst started covering Supernus Pharmaceuticals with a positive view. The initiation was among several analyst coverage starts noted for Monday.
- AnalystBenzinga
JP Morgan starts Iambic Therapeutics coverage with Overweight rating and $22 price target
JP Morgan began covering Iambic Therapeutics with an Overweight rating and set a $22 price target. The rating reflects the bank's positive view on the stock.
- AnalystBenzinga
Citigroup starts Iambic Therapeutics coverage with Buy rating and $22 price target
Citigroup began covering Iambic Therapeutics and rated the shares Buy. The firm set a $22 price target on the stock.
- AnalystBenzinga
B of A Securities starts Iambic Therapeutics coverage with Buy rating and $30 price target
B of A Securities began covering Iambic Therapeutics with a Buy rating. The firm set a price target of $30.
- ProductBenzinga
Iambic Therapeutics reports new IAM1363 data at ESMO Congress 2026
The company gave an update on its IAM1363 inhibitor, sharing clinical findings at the ESMO Congress 2026. The presentation covers results from the drug's ongoing study.
Live IAM chart with trend icons on every timeframe, key levels, dark pool and options flow, news alerts, and Ask GOAX for a full analysis on demand.
Start free 7-day trialFrequently asked questions
Is IAM bullish or bearish today?
IAM daily trend: Uptrend (starting) — turns down below $5.95. SEPT signal: Accumulation (Strong Bearish). Updated Nov 10, 2026.
What is IAM's trend on each timeframe?
Daily: Uptrend (starting); 4 hour: Leaning Bullish; 1 hour: Expanding; 15 min: Leaning Bearish; 5 min: Expanding.
What are IAM support and resistance levels?
Support: $11.00, $7.00. Resistance: $13.96, $25.00. Last price $13.38.
Are insiders buying or selling IAM?
Insider signal: Neutral. Last 30 days: 0 buys, 0 sells.
What is the latest news on IAM?
Nov 9, 2026: Supernus Pharmaceuticals receives bullish analyst coverage initiation · Nov 9, 2026: JP Morgan starts Iambic Therapeutics coverage with Overweight rating and $22 price target · Nov 9, 2026: Citigroup starts Iambic Therapeutics coverage with Buy rating and $22 price target